485 related articles for article (PubMed ID: 16207722)
21. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.
Malinge S; Monni R; Bernard O; Penard-Lacronique V
Oncogene; 2006 Jun; 25(25):3589-97. PubMed ID: 16434962
[TBL] [Abstract][Full Text] [Related]
22. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.
Li ZW; Chu W; Hu Y; Delhase M; Deerinck T; Ellisman M; Johnson R; Karin M
J Exp Med; 1999 Jun; 189(11):1839-45. PubMed ID: 10359587
[TBL] [Abstract][Full Text] [Related]
23. Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway.
Sato S; Fujita N; Tsuruo T
J Biol Chem; 2004 Aug; 279(32):33759-67. PubMed ID: 15175348
[TBL] [Abstract][Full Text] [Related]
24. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
25. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.
Mattioli I; Sebald A; Bucher C; Charles RP; Nakano H; Doi T; Kracht M; Schmitz ML
J Immunol; 2004 May; 172(10):6336-44. PubMed ID: 15128824
[TBL] [Abstract][Full Text] [Related]
26. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
27. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation.
Zheng Z; Li H; Zhang Z; Meng J; Mao D; Bai B; Lu B; Mao P; Hu Q; Wang H
J Immunol; 2011 Sep; 187(5):2202-12. PubMed ID: 21810613
[TBL] [Abstract][Full Text] [Related]
28. Caspase inhibition sensitizes inhibitor of NF-kappaB kinase beta-deficient fibroblasts to caspase-independent cell death via the generation of reactive oxygen species.
May MJ; Madge LA
J Biol Chem; 2007 Jun; 282(22):16105-16. PubMed ID: 17430892
[TBL] [Abstract][Full Text] [Related]
29. Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation.
Tsuchiya Y; Asano T; Nakayama K; Kato T; Karin M; Kamata H
Mol Cell; 2010 Aug; 39(4):570-82. PubMed ID: 20797629
[TBL] [Abstract][Full Text] [Related]
30. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
31. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase.
Zhang L; Cui R; Cheng X; Du J
Cancer Res; 2005 Jan; 65(2):457-64. PubMed ID: 15695387
[TBL] [Abstract][Full Text] [Related]
32. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC
Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
[TBL] [Abstract][Full Text] [Related]
33. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.
O'Mahony A; Lin X; Geleziunas R; Greene WC
Mol Cell Biol; 2000 Feb; 20(4):1170-8. PubMed ID: 10648602
[TBL] [Abstract][Full Text] [Related]
34. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.
Sakurai H; Suzuki S; Kawasaki N; Nakano H; Okazaki T; Chino A; Doi T; Saiki I
J Biol Chem; 2003 Sep; 278(38):36916-23. PubMed ID: 12842894
[TBL] [Abstract][Full Text] [Related]
36. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.
Sizemore N; Lerner N; Dombrowski N; Sakurai H; Stark GR
J Biol Chem; 2002 Feb; 277(6):3863-9. PubMed ID: 11733537
[TBL] [Abstract][Full Text] [Related]
37. Investigation of interleukin 1beta-mediated regulation of NF-kappaB activation in colonic cells reveals divergence between PKB and PDK-transduced events.
Parhar K; Eivemark S; Assi K; Gómez-Muñoz A; Yee A; Salh B
Mol Cell Biochem; 2007 Jun; 300(1-2):113-27. PubMed ID: 17136479
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88.
Chen BC; Wu WT; Ho FM; Lin WW
J Biol Chem; 2002 Jul; 277(27):24169-79. PubMed ID: 11976320
[TBL] [Abstract][Full Text] [Related]
39. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
[TBL] [Abstract][Full Text] [Related]
40. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
